Cui Tianxiang,Sun Jianguo,Zhang Yujing.Comparison of three methods of treatments in patients with early stage primary gastric diffuse large-B cell lymphoma[J].Chinese Journal of Radiological Medicine and Protection,2015,35(7):514-517
Comparison of three methods of treatments in patients with early stage primary gastric diffuse large-B cell lymphoma
Received:October 20, 2014  
DOI:10.3760/cma.j.issn.0254-5098.2015.07.008
KeyWords:Primary gastric diffuse large B cell lymphoma  Early stage  Methods of treatment  Curative effect
FundProject:
Author NameAffiliationE-mail
Cui Tianxiang Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China  
Sun Jianguo Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China  
Zhang Yujing 华南肿瘤学国家重点实验室 中山大学肿瘤防治中心放疗科 zhangyj@sysucc.org.cn 
Hits: 2714
Download times: 2460
Abstract::
      Objective To compare the therapeutic effects of three therapeutics to earlier primary gastric diffuse large B cell lymphoma(PG-DLBCL). Methods By reviewing a data-base of 66 patients with earlier PG-DLBCL from Aug 2000 to Oct 2011 were enrolled, patients were divided into chemotherapy alone(21 cases), radiotherapy combined with chemotherapy(22 cases) and surgery followed chemotherapy group(23 cases), and to comparing the prognosis of the three therapeutics. Results The complete remission rates(CR) of the three groups was 47.6%, 77.3%, 65.2%(P > 0.05). The median progression-free survival(PFS)of the three groups in 66 patients was 61.5, 90.4 and 79.1 months, the radiotherapy combined group was proven to be significantly better than chemotherapy alone group and surgery followed chemotherapy group(χ2=6.726, P<0.05). The 3-year survival rate of the three groups was 81.6%, 90.5% and 82.6%. The five year survival rate was 72.5%, 90.5%, 82.6%. There was no significant difference(P>0.05) in 3-year survival rate and 5-year survival rate. Conclusions Radiotherapy combined with chemotherapy can significantly improve the PFS without increasing the risk of other adverse outcomes, and could be the first treatment way for the earlier PG-DLBCL.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9057389  On-line:0

v
Scan QR Code
&et=8C10CEA789A144B8D97FFA0DF64E418D59C9CCFE7A61BB44DF67C26F9D417C4548CA927170BE041D10175583F8AD164E4386783F49E2F84A8F421124E334C6B690857F88BAE04AB7A7D7513CFDCC9B4A536E4C97B83C3E5E80D17CEA1899B1AF6E36D584CCA9599D0A10F608BE8433B289A5F49B1F224E70&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FFD10F7019FAA9EC&aid=1860F2A1EC2771888273B5262A4F4212&vid=&iid=DF92D298D3FF1E6E&sid=C4BBAD7A2DCC89BC&eid=5A751AE9FA58A3FB&fileno=20150708&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FFD10F7019FAA9EC"; var my_aid="1860F2A1EC2771888273B5262A4F4212";